跳至主要内容
临床试验/NCT02698046
NCT02698046Unknown3 期

Oral Iron Therapy in Chronic Heart Failure Patients: a Randomized, Placebo-controlled and Double-blind Clinical Trial (Pilot Study) of Efficiency

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2015年8月最近更新:
适应症

试验速览

阶段
3 期
入组人数
36
试验地点
2
主要终点
Biochemical parameter of serum transferrin saturation

研究概览

简要总结

This study is design to evaluate the effectiveness of oral iron therapy in patients with heart failure and identify the central and peripheral mechanisms involved in the improvement of functional capacity after intervention. The investigation includes subjective and objective measures on exercise performance and heart function after intervention, and the tolerability of oral iron treatment.

详细描述

This is a placebo-controlled, double-blind and randomized clinical trial that will include patients with symptomatic stable chronic heart failure (New York Heart Association Functional Class II or III), with diagnosis of iron deficiency (ferritin <100 ng / dL or ferritin between 100 - 300 ng / dL and transferrin saturation <20%) followed in an outpatient clinic. The enrolled patients (n = 36) will be randomly allocated in the ratio 2:1 to treatment with 60 mg of elemental iron orally (n = 24) or placebo administration (n = 12), 3 times daily for 4 months. The primary outcome investigated will be an increase of the transferrin saturation ≥ 10 percentage points between baseline and after the intervention. Secondary outcomes of the study will be the change in iron stores, red blood cell indices, neurohumoral activation, left ventricular systolic function, functional capacity, mechanoreflex activity, and quality life score.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Biochemical parameter of serum transferrin saturation

时间窗: 4 months

次要结局

  • Biochemical parameter of serum ferritin(4 months)
  • Ejection fraction of the left ventricle on doppler echocardiographic study(4 months)
  • Blood pressure results during mechanoreflex evaluation(4 months)
  • Biochemical parameter of hemoglobin in the hemogram analysis(4 months)
  • Biochemical parameter of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) serum levels(4 months)
  • Heart rate results during mechanoreflex evaluation(4 months)
  • Volume of oxygen consumed at peak exercise during cardiopulmonary exercise testing(4 months)
  • Volume of oxygen consumed results during mechanoreflex evaluation(4 months)
  • Total score of physical, emotional, and overall dimensions domains of the Minnesota Living with Heart Failure Questionnaire(4 months)
  • Volume of oxygen consumed at anaerobic threshold during cardiopulmonary exercise testing(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaqueline Rodrigues de Souza Gentil

Master degree

University of Sao Paulo

研究点 (2)

Loading locations...

相似试验